We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.65B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+8.66%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$1.05B
AUM Growth
+$87.6M
Cap. Flow
+$11M
Cap. Flow %
1.05%
Top 10 Hldgs %
25.51%
Holding
257
New
6
Increased
69
Reduced
106
Closed
4

Top Buys

Rank Stock Value
1
MRSH
Marsh
MRSH
+$16.4M
2
ATR icon
AptarGroup
ATR
+$2.92M
3
CVX icon
Chevron
CVX
+$970K
4
WM icon
Waste Management
WM
+$911K
5
MSFT icon
Microsoft
MSFT
+$677K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.49M
2
AAPL icon
Apple
AAPL
+$1.01M
3
PM icon
Philip Morris
PM
+$958K
4
CELG
Celgene Corp
CELG
+$924K
5
XOM icon
ExxonMobil
XOM
+$883K

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Healthcare 16.26%
3 Miscellaneous 13.33%
4 Financials 11.97%
5 Industrials 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$4.18T
$12.2M 1.16%
182,680
+3,260
+2% +$210K
TMO icon
27
Thermo Fisher Scientific
TMO
$237B
$11.9M 1.13%
36,582
-227
-0.6% -$68.8K
SYK icon
28
Stryker
SYK
$108B
$11.8M 1.12%
56,250
+1,974
+4% +$410K
NEE icon
29
NextEra Energy
NEE
$169B
$11.1M 1.05%
183,144
-3,060
-2% -$179K
CVS icon
30
CVS Health
CVS
$121B
$10.9M 1.04%
146,598
+5,615
+4% +$394K
TEL icon
31
TE Connectivity
TEL
$58.3B
$10.7M 1.02%
112,050
+2,316
+2% +$214K
ROP icon
32
Roper Technologies
ROP
$38B
$10.7M 1.02%
30,223
+74
+0.2% +$25.6K
VZ icon
33
Verizon
VZ
$214B
$10.6M 1.01%
173,286
+2,066
+1% +$125K
GIS icon
34
General Mills
GIS
$19.6B
$10.1M 0.96%
188,324
-946
-0.5% -$49.8K
PEP icon
35
PepsiCo
PEP
$185B
$10.1M 0.96%
73,668
+752
+1% +$102K
MIDD icon
36
Middleby
MIDD
$5.02B
$9.21M 0.88%
84,103
+365
+0.4% +$41.9K
ABT icon
37
Abbott
ABT
$177B
$9.08M 0.86%
104,491
-314
-0.3% -$26.3K
DLTR icon
38
Dollar Tree
DLTR
$21.2B
$8.91M 0.85%
94,738
+171
+0.2% +$17.9K
MRK icon
39
Merck
MRK
$355B
$8.79M 0.84%
101,262
-464
-0.5% -$38.1K
AFL icon
40
Aflac
AFL
$58.9B
$8.47M 0.81%
160,041
-695
-0.4% -$36.9K
QQQ icon
41
Invesco QQQ Trust
QQQ
$474B
$8.37M 0.8%
39,370
-791
-2% -$158K
DHR icon
42
Danaher
DHR
$147B
$7.95M 0.76%
58,423
-1,517
-3% -$192K
JPM icon
43
JPMorgan Chase
JPM
$937B
$7.95M 0.76%
57,025
+3
+0% +$385
SPGI icon
44
S&P Global
SPGI
$122B
$7.7M 0.73%
28,206
– –
MCD icon
45
McDonald's
MCD
$179B
$7.36M 0.7%
37,264
– –
XOM icon
46
ExxonMobil
XOM
$696B
$7.17M 0.68%
102,805
-12,767
-11% -$883K
SSNC icon
47
SS&C Technologies
SSNC
$19.1B
$6.9M 0.66%
112,326
-3,825
-3% -$214K
IDXX icon
48
Idexx Laboratories
IDXX
$40.2B
$6.75M 0.64%
25,855
-70
-0.3% -$18.4K
GILD icon
49
Gilead Sciences
GILD
$181B
$6.74M 0.64%
103,762
-2,048
-2% -$133K
ABBV icon
50
AbbVie
ABBV
$465B
$6.51M 0.62%
73,572
+225
+0.3% +$18.7K
1
2
3 4 5

Similar funds

MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
OHIF
Oriental Harbor Investment Fund Hong Kong $1.65B AUM 184.75% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

Boston Family Office's Q4 2019 Portfolio in Review

As of Q4 2019, Boston Family Office held 257 positions worth $1.05B, up 9.1% from $964M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.9%. Boston Family Office opened 6 new positions and exited 4, leaving the 257-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Boston Family Office's largest Q4 2019 buy was Constellation Brands: 1,475 shares worth $280K.
  • Boston Family Office added most to Marsh in Q4 2019, an estimated $16.4M increase.
  • Boston Family Office's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $1.49M.
  • Boston Family Office fully exited Celgene Corp in Q4 2019, selling an estimated $924K.
  • Boston Family Office's ten largest holdings make up 26% of its $1.05B portfolio in Q4 2019.
  • Boston Family Office opened 6 new positions and closed 4 in Q4 2019.
  • Boston Family Office's portfolio value rose 9.1% quarter-over-quarter to $1.05B.

Based on Boston Family Office's 13F filing for Q4 2019, filed 5 Feb 2020.